Scott, D.L. and Stevenson, M.D. (2017) Treating active rheumatoid arthritis with Janus kinase inhibitors. Lancet, 390 (10093). pp. 431-432. ISSN 0140-6736
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2017 Elsevier. This is an author produced version of a paper subsequently published in Lancet. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 27 Jun 2017 13:42 |
Last Modified: | 18 Aug 2023 14:13 |
Status: | Published |
Publisher: | Elsevier |
Refereed: | Yes |
Identification Number: | 10.1016/S0140-6736(17)31659-8 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:118272 |
Download
Filename: tofacitinib commentary 2nd june 2017 revised all changes accepted.pdf
Licence: CC-BY-NC-ND 4.0